Compare PROF & GLOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | GLOO |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 276.7M |
| IPO Year | 2017 | 2025 |
| Metric | PROF | GLOO |
|---|---|---|
| Price | $7.44 | $2.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $11.14 | ★ $11.17 |
| AVG Volume (30 Days) | 184.5K | ★ 285.7K |
| Earning Date | 11-05-2026 | 09-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 41.17 |
| EPS | N/A | ★ N/A |
| Revenue | $16,098,000.00 | ★ $94,660,000.00 |
| Revenue This Year | $61.76 | $111.41 |
| Revenue Next Year | $70.98 | $42.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 50.73 | ★ 307.74 |
| 52 Week Low | $4.91 | $2.60 |
| 52 Week High | $8.95 | $9.98 |
| Indicator | PROF | GLOO |
|---|---|---|
| Relative Strength Index (RSI) | 62.40 | 39.03 |
| Support Level | $6.38 | $2.60 |
| Resistance Level | $7.92 | $3.11 |
| Average True Range (ATR) | 0.50 | 0.19 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 75.61 | 40.58 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Gloo Holdings Inc is engaged in building a technology platform company. It has provided a breadth of products, services, and solutions to the two primary stakeholders at the core of the faith and flourishing ecosystem: (1) network capability providers (NCPs) and (2) the churches and frontline organizations (CFLs) it serves. The company serves as a digital infrastructure between NCPs and CFLs. By facilitating efficient exchange between the two, Gloo enables both sides to succeed; CFLs gain access to resources and NCPs benefit from efficient distribution and targeted reach. This creates a virtuous cycle, strengthening the platform with each interaction. The Gloo platform includes a suite of technology, marketplace, and service solutions offered directly from Gloo or from Gloo's subsidiaries.